$24.83
-0.47-1.86%
Last update: Oct 30, 7:57 PM
uniQure NV (QURE) Stock Price, Quote, News & History
QURENASDAQ
U.S. stocks rose as Nasdaq gained 100+ points; HPE jumped 5.1% on stronger networking guidance and a Vultr AI rack order.
You can purchase shares of uniQure (NASDAQ:QURE) through any online brokerage.
Other companies in uniQure’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
uniQure has a consensus price target of $53.75.
The stock price for uniQure (NASDAQ: QURE) is $26.5 last updated October 30, 2026 at 7:57 PM EDT.
There are no upcoming dividends for uniQure.
uniQure does not have any upcoming earnings scheduled.
There is no upcoming split for uniQure.
uniQure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The...
